Hi-Q Team

No Matched Results

With a passion for empowering people to lead healthier lives, Hi-Q has been investing in the research and development of functional ingredients since 1998.

Quality through Scientific Research

Hi-Q developed the advanced hydrolysis technology to extract the bioactive Low Molecular Weight Fucoidan (Oligo Fucoidan) from brown seaweed. Oligo Fucoidan is verified by scientific studies and human clinical trials in multi-health benefits.

Experts Network for Advanced Research and Solution

Hi-Q has a talented and experienced research and development team that has published over 60 scientific papers on the bioactivity and health benefits of Oligo Fucoidan and Fucoxanthin. In addition to the own expert teams, Hi-Q collaborates with leading research institutions, hospitals and universities for advanced research and solution.

Rigorous scientific research

20+

Industry-Government-Academia Collaboration

National Health Research Institutes (NHRI), Taiwan
Fisheries Research Institute (FRI), Council of Agriculture, Taiwan
National Atomic Energy Commission of Argentina
National Defense Medical Center
National Cheng Kung University
National Sun Yat-sen University
National Taiwan Ocean University
National Taiwan Sport University
National Taiwan University
National Taiwan University of Science and Technology
National Yang-Ming University
Asia University
Chinese Culture University
Hungkuang University
Taipei Medical University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Rui Jin Hospital (Shanghai Jiao Tong University)
Chang Gung Memorial Hospital
Kuang Tien General Hospital
Shuang Ho Hospital
Taipei Municipal Wangfang Hospital
Taipei Tzu Chi Hospital
Zhongshan Hospital (Shanghai Medical College of Fudan University)

Hi-Q continues the investment in Scientific Research and Human Clinical Trials of Oligo Fucoidan

60+

SCI Scientific Publications

15+

Human Clinical Trials

Clinicals Trials Related to Cancer
No. Unit Research Topics Status
1 Kaohsiung Medical University Hospital Colorectal cancer Finished
2 Kuang Tien General Hospital/ Cheng Lung cancer Unblinding
3 Kaohsiung Medical University Hospital Colorectal cancer Unblinding
4 Saint Mary's Hospital Luodong Radiotherapy side effects In progress
5 Saint Mary's Hospital Luodong Chemotherapy side effects In progress
6 Shanghai Zhongshan Hospital of Fudan University Liver cancer Unblinding
7 National Taiwan University Hospital Head and neck cancer In progress
Clinicals Trials in Other Topics
No. Unit Research Topics Status
1 Taipei Municipal Wan Fang Hospital Fatty liver, Liver health Finished
2 Kuang-Tien General Hospital Asthma Finished
3 Shuang Ho Hospital Chronic kidney disease Unblinding
4 Chang Gung Memorial Hospital Atopic dermatitis Unblinding
5 Taipei Medical University Uterine fibroids In progress
6 Taipei Municipal Wan Fang Hospital Functional Unblinding
7 National Taiwan University Hospital Head and neck cancer In progress
8 Chang Gung Memorial Hospital Gut microbiome In progress
9 National Cheng Kung University Hospital Sarcopenia In progress

Key Area

Adjunct Cancer Research

Pharmacologically, Oligo Fucoidan has various biological activities, such as anti-cancer, anti-inflammatory, and immunomodulatory functions. Specifically, Hi-Q are investing in development of cancer nutrition to fulfill the ongoing need to proper and adjunct nutrition to cancer patients as they suffer from cachexia.

Ming-De Yan, Ph.D.

Director of Research Development